Inventor profile of:

Stephane CIBLAT

City:

Montreal

Country:

Canada

Published Applications:

72

Last publication date:

2026-06-04

Top Assignees for applications by Stephane CIBLAT

The entities that hold a legal rights for patent applications filed by inventor CIBLAT Stephane:

Recent patent applications by CIBLAT Stephane

Stephane CIBLAT from Montreal, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-06-04
US20260152500A1
Chemistry; metallurgy

PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3

#2 | 2026-05-07
US20260125384A1
Chemistry; metallurgy

INDAZOLE INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF

#3 | 2026-05-07
US20260125383A1
Chemistry; metallurgy

INDAZOLE INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF

#4 | 2026-02-12
US20260042757A1
Chemistry; metallurgy

PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3

#5 | 2026-02-05
US20260035393A1
Chemistry; metallurgy

INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7)

#6 | 2026-01-08
US20260008768A1
Chemistry; metallurgy

UREA DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF

#7 | 2026-01-08
US20260007684A1
Human necessities

AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF

#8 | 2025-10-02
US20250304537A1
Chemistry; metallurgy

HETEROARENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME

#9 | 2025-08-14
US20250257077A1
Chemistry; metallurgy

BRIDGED BICYCLIC HETEROCYCLOALKYL PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 INHIBITORS

#10 | 2024-12-12
US20240409540A1
Chemistry; metallurgy

PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 INHIBITORS

#11 | 2024-11-21
US20240383896A1
Chemistry; metallurgy

PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 INHIBITORS

#12 | 2024-11-07
US20240368131A1
Chemistry; metallurgy

OXOINDOLINYL AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF

#13 | 2024-10-31
US20240360165A1
Chemistry; metallurgy

INHIBITORS OF CYCLIN DEPENDENT KINASE 7 (CDK7)

#14 | 2024-10-31
US20240360130A1
Chemistry; metallurgy

Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors

#15 | 2024-10-31
US20240360129A1
Chemistry; metallurgy

Compounds for inhibiting NLRP3 and uses thereof

#16 | 2024-08-15
US20240270740A1
Chemistry; metallurgy

INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF

#17 | 2024-08-15
US20240270722A1
Chemistry; metallurgy

POLO LIKE KINASE 4 INHIBITORS

#18 | 2024-07-25
US20240246976A1
Chemistry; metallurgy

5-(2,5-DIFLUOROPHENYL)PYRROLIDIN-1-YL)-3-(1H-PYRAZOL-1-YL)PYRAZOLO [1,5-A]PYRIMIDINE DERIVATIVES AND RELATED COMPOUNDS AS TRK KINASE INHIBITORS FOR TREATING CANCER

#19 | 2024-06-20
US20240199606A1
Chemistry; metallurgy

PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3

#20 | 2024-05-30
US20240174668A1
Chemistry; metallurgy

PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3

#21 | 2024-05-30
US20240174661A1
Chemistry; metallurgy

PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 INHIBITORS

#22 | 2024-04-18
US20240124426A1
Chemistry; metallurgy

Polo like kinase 4 inhibitors

#23 | 2023-11-16
US20230365537A1
Chemistry; metallurgy

Polo like kinase 4 inhibitors

#24 | 2023-05-11
US20230144106A1
Chemistry; metallurgy

COMPOUNDS FOR THE MODULATION OF MYC ACTIVITY

#25 | 2023-04-20
US20230124248A1
Chemistry; metallurgy

5-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1H-pyrazol-1-yl)pyrazolo [1,5-A]pyrimidine derivatives and related compounds as Trk kinase inhibitors for treating cancer

#26 | 2023-03-09
US20230076820A1
Chemistry; metallurgy

Substituted Pyrazole Compounds and Methods of Using Them for Treatment of Hyperproliferative Diseases

#27 | 2023-03-02
US20230062491A1
Chemistry; metallurgy

INHIBITORS OF CYCLIN DEPENDENT KINASE 7 (CDK7)

#28 | 2022-09-29
US20220305014A1
Human necessities

INHIBITORS OF CYCLIN DEPENDENT KINASE 7 (CDK7)

#29 | 2022-07-28
US20220235055A1
Chemistry; metallurgy

5-(2,5-DIFLUOROPHENYL)PYRROLIDIN-1-YL)-3-(1H-PYRAZOL-1-YL)PYRAZOLO [1,5-A]PYRIMIDINE DERIVATIVES AND RELATED COMPOUNDS AS TRK KINASE INHIBITORS FOR TREATING CANCER

#30 | 2022-02-17
US20220048927A1
Chemistry; metallurgy

Compounds for the modulation of Myc activity

#31 | 2022-01-06
US20220000890A1
Human necessities

Inhibitors of cyclin dependent kinase 7 (CDK7)

#32 | 2021-12-30
US20210403495A1
Chemistry; metallurgy

Inhibitors of cyclin-dependent kinase 7 (CDK7)

#33 | 2021-12-16
US20210386693A1
Human necessities

METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID

#34 | 2021-12-09
US20210379065A1
Human necessities

Inhibitors of cyclin dependent kinase 7 (CDK7)

#35 | 2021-07-22
US20210221820A1
Chemistry; metallurgy

COMPOUNDS FOR THE MODULATION OF MYC ACTIVITY

#36 | 2021-06-24
US20210188833A1
Chemistry; metallurgy

COMPOUNDS FOR THE MODULATION OF MYC ACTIVITY

#37 | 2021-05-20
US20210147431A1
Chemistry; metallurgy

PYRROLOTRIAZINE COMPOUNDS AND METHODS OF INHIBITING TAM KINASES

#38 | 2021-04-01
US20210094956A1
Chemistry; metallurgy

5-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1h-pyrazol-1-yl)pyrazolo[1,5-a]pyrimidine derivatives and related compounds as Trk kinase inhibitors for treating cancer

#39 | 2021-03-04
US20210061803A1
Chemistry; metallurgy

INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7)

#40 | 2020-10-08
US20200317676A1
Chemistry; metallurgy

Pyrrolotriazine compounds and methods of inhibiting TAM kinases

#41 | 2020-09-17
US20200291018A1
Chemistry; metallurgy

TAM KINASE INHIBITORS

#42 | 2020-08-20
US20200261424A1
Human necessities

Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto

#43 | 2020-08-13
US20200253897A1
Human necessities

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

#44 | 2020-06-18
US20200190126A1
Chemistry; metallurgy

Inhibitors of cyclin-dependent kinase 7 (CDK7)

#45 | 2020-03-05
US20200069656A1
Human necessities

Methods of using substituted pyrazole and pyrazole compounds and for treatment of hyperproliferative diseases

#46 | 2020-01-09
US20200009086A1
Human necessities

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

#47 | 2019-11-14
US20190345152A1
Chemistry; metallurgy

Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases

#48 | 2019-11-07
US20190337940A1
Chemistry; metallurgy

Inhibitors of cyclin-dependent kinase 7 (CDK7)

#49 | 2019-09-26
US20190292167A1
Chemistry; metallurgy

HETEROAROMATIC COMPOUNDS USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES

#50 | 2019-08-08
US20190241541A1
Chemistry; metallurgy

Heteroaromatic compounds useful for the treatment of proliferative diseases

#51 | 2019-04-25
US20190119285A1
Chemistry; metallurgy

Pyrazolopyrimidinone compounds and uses thereof

#52 | 2019-02-14
US20190048019A1
Chemistry; metallurgy

Compounds for the modulation of MYC activity

#53 | 2019-01-31
US20190031642A1
Chemistry; metallurgy

Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)

#54 | 2018-12-13
US20180354972A1
Chemistry; metallurgy

Compounds for the modulation of Myc activity

#55 | 2018-11-08
US20180319772A1
Chemistry; metallurgy

Inhibitors of cyclin-dependent kinase 7 (CDK7)

#56 | 2018-11-01
US20180311218A1
Human necessities

Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto

#57 | 2018-07-26
US20180208578A1
Chemistry; metallurgy

Inhibitors of cyclin-dependent kinase 7 (CDK7)

#58 | 2018-06-14
US20180162851A1
Chemistry; metallurgy

Compounds for the modulation of myc activity

#59 | 2017-06-29
US20170183355A1
Chemistry; metallurgy

Inhibitors of cyclin-dependent kinase 7 (CDK7)

#60 | 2017-04-06
US20170095430A1
Human necessities

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

#61 | 2016-09-15
US20160264554A1
Chemistry; metallurgy

Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)

#62 | 2016-09-15
US20160264552A1
Chemistry; metallurgy

HETEROMAROMATIC COMPOUNDS USEFUL FOR THE TREATMENT OF PROLFERATIVE DISEASES

#63 | 2016-09-15
US20160264551A1
Chemistry; metallurgy

HETEROAROMATIC COMPOUNDS USEFUL FOR THE TREATMENT OF PROLFERATIVE DISEASES

#64 | 2016-08-04
US20160220519A1
Human necessities

AMINO ACID DERIVATIVES FOR THE TREATMENT OF NEUROPATHIC PAIN

#65 | 2015-09-24
US20150266814A1
Chemistry; metallurgy

METHODS, COMPOUNDS, AND COMPOSITIONS FOR DELIVERING 1,3-PROPANEDISULFONIC ACID

#66 | 2014-08-07
US20140220122A1
Chemistry; metallurgy

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

#67 | 2014-06-19
US20140171507A1
Chemistry; metallurgy

Amino acid derivatives for the treatment of neuropathic pain

#68 | 2012-08-16
US20120208876A1
Human necessities

AMINO ACID DERIVATIVES FOR THE TREATMENT OF NEUROPATHIC PAIN

#69 | 2012-08-16
US20120208850A1
Chemistry; metallurgy

Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid

#70 | 2011-10-27
US20110263534A1
Chemistry; metallurgy

Phosphonated Rifamycins and uses thereof for the prevention and treatment of bone and joint infections

#71 | 2010-05-06
US20100113333A1
Chemistry; metallurgy

Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections

#72 | 2008-06-19
US20080146642A1
Human necessities

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

InventorID:

806967 ⎘